We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
NC6OB | Nanollose Limited | 0.008 | 0.004 | 100.00% | 200,000 | 2 |
LPDOE | Lepidico Ltd | 0.002 | 0.001 | 100.00% | 1,583,642 | 4 |
RC1O | Redcastle Resources Ltd | 0.005 | 0.002 | 66.67% | 1,120,998 | 4 |
AHN | Athena Resources Limited | 0.003 | 0.001 | 50.00% | 350,000 | 2 |
YPB | YPB Group Ltd | 0.003 | 0.001 | 50.00% | 5,258,747 | 17 |
APC | Australian Potash Limited | 0.0015 | 0.0005 | 50.00% | 2,375,610 | 18 |
NC6 | Nanollose Limited | 0.032 | 0.009 | 39.13% | 225,424 | 6 |
LGMO | Legacy Minerals Holdings Ltd | 0.065 | 0.018 | 38.30% | 297,056 | 7 |
WNX | Wellnex Life Ltd | 0.029 | 0.008 | 38.10% | 3,119,671 | 36 |
POS | Poseidon Nickel Limited | 0.006 | 0.0015 | 33.33% | 23,371,388 | 192 |
OSXO | Osteopore Limited | 0.012 | 0.003 | 33.33% | 225,000 | 1 |
VICTORIA, BC, May 14, 2024 /PRNewswire/ -Â Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphereâ„¢ technology to optimize drug delivery for applications with significant unmet need, today announced that initial results from the ongoing Phase 1b study of EP-104GI for the treatment of eosinophilic esophagitis will be presented at the upcoming Digestive Disease Week ("DDW") Annual Meeting 2024.
SAN DIEGO, May 14, 2024 /PRNewswire/ --Â Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its fiscal third quarter ended March 31, 2024, and recent corporate developments.
Organic growth investments expected to accelerate financial performance in late fiscal 2026 and into fiscal 2027 Company provides update on third and fourth quarter fiscal 2024 LEBANON, Tenn., May 16, 2024 /PRNewswire/ -- Cracker Barrel Old Country Store, Inc. ("Cracker Barrel" or the "Company") (Nasdaq: CBRL) today provided an update on its strategic transformation plan and announced changes to its capital allocation.
TORONTO, May 16, 2024 /PRNewswire/ --Â Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China, today announced the Company has cooperated with Canada's B. Braun Biochip Technology Group to establish Visionary Biotechnology Group Co., Ltd. in Toronto. Both economic value and social value will have an important impact. Visionary Group has a global impact in the field of biotechnology. Important value for short, medium and long term investors.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 66,258.67 | 1,019.43 | 1.56% | 1.3T | 4,221,215,673 |
ETH | Ethereum | 3,030.32 | 85.07 | 2.89% | 364.22B | 2,101,367,955 |
USDT | Tether USD | 1.00 | 0.00 | 0.00% | 97.84B | 267,965,443 |
BNB | Binance Coin | 578.32 | 8.97 | 1.58% | 91.28B | 270,963,445 |
SOL | Solana | 167.36 | 8.15 | 5.12% | 73.85B | 1,379,458,939 |
STETH | stETH | 3,017.30 | 86.83 | 2.96% | 29.58B | 4,964,667 |
XRP | Ripple | 0.5207 | 0.0049 | 0.95% | 28.4B | 288,811,877 |
USDC | USD Coin | 0.9999 | -0.0001 | -0.01% | 28.07B | 886,929,822 |
TONCOIN | Wrapped TON Coin | 6.68 | -0.069047 | -1.02% | 23.14B | 384,156,592 |
DOGE | Dogecoin | 0.15211 | 0.0024 | 1.60% | 21.78B | 347,854,831 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions